Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

8.41
Delayed Data
As of Apr 03
 +0.29 / +3.57%
Today’s Change
6.07
Today|||52-Week Range
15.72
-14.18%
Year-to-Date
CEO Says Sanofi Can Mass-Produce Hydroxychloroquine for COVID-19 Patients
Apr 03 / MotleyFool.com - Paid Partner Content
5 Healthcare Stocks That Haven't Been This Cheap in at Least 10 Years
Mar 25 / MotleyFool.com - Paid Partner Content
FDA: You Can Use Chloroquine to Treat COVID-19; EU Regulators: Not Just Yet
Apr 02 / MotleyFool.com - Paid Partner Content
Should You Invest in These 3 Buffett Stocks at Discount Prices?
Mar 25 / MotleyFool.com - Paid Partner Content
3 Ridiculously Cheap Buffett Stocks to Buy Now
Mar 31 / MotleyFool.com - Paid Partner Content
New York to Start Clinical Trials of Anti-Malaria Drugs for COVID-19
Mar 23 / MotleyFool.com - Paid Partner Content
FDA Authorizes Use of Old Malaria Drugs to Treat COVID-19
Mar 30 / MotleyFool.com - Paid Partner Content
Are These Warren Buffett Stocks a Buy at Beaten-Down Prices?
Mar 23 / MotleyFool.com - Paid Partner Content
5 Buffett Stocks You Should Be Buying Hand Over Fist
Mar 26 / MotleyFool.com - Paid Partner Content